US Presidential debate

News

The US Presidential debate barely mentioned pharma topics, but Harris did have one notable sound bite toward the very end of the night.

News

Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.